ASO Visual Abstract: Hepatic and Overall Progression-Free Survival After Percutaneous Hepatic Perfusion as First- or Second-Line Therapy for Metastatic Uveal Melanoma.

Authors

Helana Ghali
Michelle M Dugan
Shaliz Aflatooni, Lehigh Valley Health NetworkFollow
Aleena Boby
Danielle K DePalo
José Laborde
Junsung Choi
Altan F Ahmed
Jonathan S Zager

Publication/Presentation Date

10-8-2024

ISSN

1534-4681

Published In/Presented At

Ghali, H., Dugan, M. M., Aflatooni, S., Boby, A., DePalo, D. K., Laborde, J., Choi, J., Ahmed, A. F., & Zager, J. S. (2024). ASO Visual Abstract: Hepatic and Overall Progression-Free Survival After Percutaneous Hepatic Perfusion as First- or Second-Line Therapy for Metastatic Uveal Melanoma. Annals of surgical oncology, 10.1245/s10434-024-16307-4. Advance online publication. https://doi.org/10.1245/s10434-024-16307-4

Disciplines

Medical Education | Medicine and Health Sciences

PubMedID

39377841

Department(s)

USF-LVHN SELECT Program, USF-LVHN SELECT Program Students

Document Type

Article